News > Where are we in the COVID-19 vaccine race?
Where are we in the COVID-19 vaccine race?
CNBC TV18 | 07/10/2020 02:35 PM | Click to read full article
Pfizer Inc with German partner BioNTech SE, US biotech Moderna Inc and Britain-based AstraZeneca Plc in conjunction with the University of Oxford researchers could provide early analyses of data from their various large trials over the next two months.
China launched an emergency use program in July aimed at essential workers and Russia’s Gamaleya Institute has begun a 40,000-person late-stage trial and is expected to have early data at the end of October or early November.
